Kedrion – News Coronavirus (SARS-CoV-2)

"With regard to this epidemiological situation caused by Coronavirus Covid-19 in Italy, Kedrion informs that the company had taken action following the guidelines of International’s authorities, national and local, and doing everything was deemed necessary to protect the safety and security of the employees and to ensure continuous business operations.

As the situation evolves continuously measures taken in these hours, based on principal of precaution, may be updated depending on the epidemiological evolution of this disease and depending on what will be set by the Competent Authorities.

Kedrion is totally aligned with the declarations of the Italian and International medical and scientific communities, and with the Industry Association in particular the Plasma Protein Therapeutics Association, whose more recent statement clarify that thanks to the “strict screening procedures for plasma donors and the established processes of virus inactivation and removal during manufacturing of plasma-derived products, the SARS-CoV-2 is not a concern for the safety margins of plasma protein therapies manufactured by PPTA member companies."